789 related articles for article (PubMed ID: 15914211)
41. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
42. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia.
Majumdar S; Mondal BC; Ghosh M; Dey S; Mukhopadhyay A; Chandra S; Dasgupta UB
Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869
[TBL] [Abstract][Full Text] [Related]
43. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
44. Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma.
Jahnke V; Strange R; Matthias C; Fryer A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S147-9. PubMed ID: 9065651
[TBL] [Abstract][Full Text] [Related]
45. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
46. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease.
Arif E; Vibhuti A; Alam P; Deepak D; Singh B; Athar M; Pasha MA
Clin Chim Acta; 2007 Jul; 382(1-2):37-42. PubMed ID: 17442289
[TBL] [Abstract][Full Text] [Related]
47. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
48. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
[TBL] [Abstract][Full Text] [Related]
49. Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.
Forestiero FJ; Cecon L; Hirata MH; de Melo FF; Cardoso RF; Cerda A; Hirata RD
Clin Chim Acta; 2013 Jan; 415():215-9. PubMed ID: 23099118
[TBL] [Abstract][Full Text] [Related]
50. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
[TBL] [Abstract][Full Text] [Related]
53. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay.
Bailliet G; Santos MR; Alfaro EL; Dipierri JE; Demarchi DA; Carnese FR; Bianchi NO
Mutat Res; 2007 Mar; 627(2):171-7. PubMed ID: 17194620
[TBL] [Abstract][Full Text] [Related]
54. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
[No Abstract] [Full Text] [Related]
55. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
[TBL] [Abstract][Full Text] [Related]
56. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
[TBL] [Abstract][Full Text] [Related]
57. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
[TBL] [Abstract][Full Text] [Related]
58. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
59. [Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer].
Gao JP; Huang YD; Yang GZ; Yang YQ
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):32-5. PubMed ID: 12680328
[TBL] [Abstract][Full Text] [Related]
60. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]